Cargando…
A multicentre prospective open-label study assessing efficacy and safety of a triple-secured fibrinogen concentrate in the treatment of postpartum haemorrhage
Autores principales: | Ducloy-Bouthors, AS, Broisin, F, Teboul, C, Jaffry, A, Waegemans, T, Padrazzi, B |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4088595/ http://dx.doi.org/10.1186/cc6445 |
Ejemplares similares
-
Tranexamic acid reduces blood loss in postpartum haemorrhage
por: Ducloy-Bouthors, A, et al.
Publicado: (2010) -
High-dose tranexamic acid reduces blood loss in postpartum haemorrhage
por: Ducloy-Bouthors, Anne-Sophie, et al.
Publicado: (2011) -
Tranexamic acid dose–response relationship for antifibrinolysis in postpartum haemorrhage during Caesarean delivery: TRACES, a double-blind, placebo-controlled, multicentre, dose-ranging biomarker study
por: Ducloy-Bouthors, Anne-Sophie, et al.
Publicado: (2022) -
Haemostatic support in postpartum haemorrhage: A review of the literature and expert opinion
por: Hofer, Stefan, et al.
Publicado: (2023) -
The role of fibrinogen in massive postpartum haemorrhage, a case report
por: van Minde, M.R.C., et al.
Publicado: (2015)